AR003985A1 - Forma cristalina switterionica de trovafloxacina, procedimiento para su preparacion y composiciones que las contienen. - Google Patents

Forma cristalina switterionica de trovafloxacina, procedimiento para su preparacion y composiciones que las contienen.

Info

Publication number
AR003985A1
AR003985A1 ARP960104121A AR10412196A AR003985A1 AR 003985 A1 AR003985 A1 AR 003985A1 AR P960104121 A ARP960104121 A AR P960104121A AR 10412196 A AR10412196 A AR 10412196A AR 003985 A1 AR003985 A1 AR 003985A1
Authority
AR
Argentina
Prior art keywords
trovafloxacin
preparation
switterionica
compositions
procedure
Prior art date
Application number
ARP960104121A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR003985A1 publication Critical patent/AR003985A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
ARP960104121A 1995-08-29 1996-08-26 Forma cristalina switterionica de trovafloxacina, procedimiento para su preparacion y composiciones que las contienen. AR003985A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
AR003985A1 true AR003985A1 (es) 1998-09-30

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104121A AR003985A1 (es) 1995-08-29 1996-08-26 Forma cristalina switterionica de trovafloxacina, procedimiento para su preparacion y composiciones que las contienen.

Country Status (30)

Country Link
EP (1) EP0850060A1 (ru)
JP (1) JP3188476B2 (ru)
KR (1) KR100343909B1 (ru)
CN (1) CN1190889A (ru)
AP (1) AP636A (ru)
AR (1) AR003985A1 (ru)
AU (1) AU704115B2 (ru)
BR (1) BR9609998A (ru)
CA (1) CA2229786C (ru)
CO (1) CO4480739A1 (ru)
CZ (1) CZ56698A3 (ru)
DZ (1) DZ2087A1 (ru)
GT (1) GT199600072A (ru)
HR (1) HRP960395B1 (ru)
HU (1) HUP9900170A3 (ru)
IL (1) IL122651A (ru)
MA (1) MA23966A1 (ru)
MY (1) MY113874A (ru)
NO (1) NO309814B1 (ru)
NZ (1) NZ312199A (ru)
OA (1) OA10669A (ru)
PE (1) PE12598A1 (ru)
PL (1) PL325170A1 (ru)
RU (1) RU2144921C1 (ru)
SK (1) SK23898A3 (ru)
TN (1) TNSN96109A1 (ru)
TR (1) TR199800339T1 (ru)
WO (1) WO1997007800A1 (ru)
YU (1) YU48396A (ru)
ZA (1) ZA967282B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
ZA967282B (en) 1998-03-02
JPH10511692A (ja) 1998-11-10
KR19990044232A (ko) 1999-06-25
MY113874A (en) 2002-06-29
EP0850060A1 (en) 1998-07-01
AU6367696A (en) 1997-03-19
IL122651A0 (en) 1998-08-16
JP3188476B2 (ja) 2001-07-16
CA2229786A1 (en) 1997-03-06
HUP9900170A3 (en) 1999-11-29
AP636A (en) 1998-04-09
AP9600853A0 (en) 1996-10-31
CO4480739A1 (es) 1997-07-09
NO980862D0 (no) 1998-02-27
MX9801664A (es) 1998-08-30
IL122651A (en) 2000-02-17
WO1997007800A1 (en) 1997-03-06
NO309814B1 (no) 2001-04-02
YU48396A (sh) 1998-12-23
BR9609998A (pt) 1999-07-06
TR199800339T1 (xx) 1998-06-22
OA10669A (en) 2000-11-06
PL325170A1 (en) 1998-07-06
NO980862L (no) 1998-02-27
TNSN96109A1 (fr) 2005-03-15
GT199600072A (es) 1998-02-14
PE12598A1 (es) 1998-03-20
KR100343909B1 (ko) 2003-04-10
MA23966A1 (fr) 1997-04-01
DZ2087A1 (fr) 2002-07-22
HUP9900170A2 (hu) 1999-05-28
HRP960395A2 (en) 1998-06-30
RU2144921C1 (ru) 2000-01-27
AU704115B2 (en) 1999-04-15
CA2229786C (en) 2002-02-19
HRP960395B1 (en) 2001-12-31
CN1190889A (zh) 1998-08-19
NZ312199A (en) 1999-06-29
CZ56698A3 (cs) 1999-02-17
SK23898A3 (en) 1999-05-07

Similar Documents

Publication Publication Date Title
UY28510A1 (es) Compuestos quimicos
CO4970821A1 (es) Nuevos macrolidos
AR034897A1 (es) Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
ECSP099451A (es) Compuestos de urea policíclicos antibacterianos
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
BRPI0513717A (pt) derivados de piridina
UY25780A1 (es) Nuevos antibióticos macrólidos
EA199901016A1 (ru) 9-оксим-производные эритромицина
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
CO4970773A1 (es) Nuevos derivados de eritromicina
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
CO6351722A2 (es) Derivados heterociclicos de la urea y sus metodos de empleo
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
UY27410A1 (es) Formas novedosas crudas cristalinas
DK1448562T3 (da) Substituerede tetracycliske pyrroloquinolonderivater egnede som phosphodiesteraseinhibitorer
AR003985A1 (es) Forma cristalina switterionica de trovafloxacina, procedimiento para su preparacion y composiciones que las contienen.
ECSP034598A (es) Compuesto lactamico
UY27324A1 (es) Nuevas sales de napsilato i
AR128066A1 (es) Compuesto heterocíclico de pirimidina y método de preparación y uso médico de los mismos
AR126914A1 (es) Inhibidores de ras novedosos
ES2135351B1 (es) Derivados de 5-aroilnaftaleno.